Syneron Medical (ELOS) Reports In-Line Q3 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
Go back to Syneron Medical (ELOS) Reports In-Line Q3 EPS
November 11, 2015 7:00 AM EST
IRVINE, Calif., Nov. 11, 2015 /PRNewswire/ --Â Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, today announced financial results for the three month period ended September 30, 2015.
Third Quarter 2015 and Recent Non-GAAP[1] Highlights:
Revenue of $62.1 million, compared to $60.3 million in the third quarter 2014, up 3% year-over-year, or 8% in constant currency
North American product sales grew 15% year-over-year
Non-GAAP gross margin of 57.0%, or 58.9% in constant currency, compared to 55.6% in Q3 2014
Non-GAAP net income of...
More
November 11, 2015 6:59 AM EST
IRVINE, Calif., Nov. 11, 2015 /PRNewswire/ -- Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, announced today that it has enhanced its North American leadership team with the appointment of Jeff Nardoci as President of its North America Body Shaping Group. In this position, Mr. Nardoci will be responsible for the development and execution of the Company's growth strategies for UltraShape and VelaShape. He will report to Bill Griffing, CEO of Syneron Candela North America.
Amit Meridor, Chief... More
